“Growing Demand Due to Increasing Prevalence of Musculoskeletal Disorders”
- The rising prevalence of musculoskeletal disorders such as osteoarthritis, tendon injuries, and ligament sprains is significantly contributing to the increased demand for Platelet Rich Plasma therapies.
- As Europe’s population ages and as the number of active sports participants grows, the incidence of joint-related disorders rises, with PRP therapies becoming a preferred non-surgical solution for treatment.
- As more individuals seek faster recovery and effective pain management options, the demand for PRP therapies, especially in orthopedic and sports medicine fields, continues to grow.
For instance,
- In 2022, the European Society of Musculoskeletal Medicine highlighted a notable increase in osteoarthritis cases, especially among the elderly population. This surge has accelerated the demand for regenerative medicine therapies such as platelet-rich plasma (PRP), which offer non-invasive, restorative treatment options aimed at alleviating joint pain and improving mobility.
- As a result of the rising prevalence of musculoskeletal disorders, there is a marked increase in the demand for PRP treatments.
